| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |